TScan Therapeutics, Inc. (TCRX)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.32
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.53
P/B Ratio
0.60
Institutional Ownership
26.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 8.02M | $7.0M | 6.17% | -- | 2026-06-30 |
| BVF INC/IL | 5.56M | $5.0M | 4.28% | -- | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 2.78M | $2.0M | 2.14% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.16M | $2.0M | 1.66% | +4.6K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.95M | $1.0M | 1.50% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.33M | $1.0M | 1.02% | -38.0K | 2026-06-30 |
| Deer Management Co. LLC | 1.25M | $1.0M | 0.96% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 1.16M | $1.0M | 0.90% | -296.7K | 2026-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.05M | $1.0M | 0.81% | +241.4K | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.01M | -- | 0.78% | +690.7K | 2026-06-30 |